ACTonDiabetes - A randomised-controlled feasibility trial of an acceptance and commitment therapy-based internet intervention for people with diabetes mellitus

ACTonDiabetes - A randomised-controlled feasibility trial of an acceptance and commitment therapy-based internet intervention for people with diabetes mellitus - ACTonDiabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013193

Enrollment

Registered

2017-11-02

Start date

2017-10-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus (type 1 and type 2) E11 E10

Interventions

Group 1: intervention group: access to the guided internet intervention "ACTonDiabetes". Participants complete one session weekly. Overall, ACTonDiabetes contains 8 sessions. One session lasts between

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: diabetes mellitus (type 1 and type2), internet access, participants agreement

Exclusion criteria

Exclusion criteria: temporary diabetes (e.g. gestational diabetes), medical objections

Design outcomes

Primary

Measure	Time frame
Feasibility: there are two measurements, respectively (T1: prior to intervention, T2: eight weeks after randomizaton). Process-related: Recruitment (strategies and figures), questions due to satisfaction with contents after each session time of measurement: Drop-out rate (T2), acceptance (questionnaire APOI (T1, T2),), adverse events (questionnaire INEP) (T1,T2)	—

Secondary

Measure	Time frame
Each measurements are questionnaires (self-report): T1: prior to intervention, T2: 8 weeks after randomization Problem Areas in Diabetes (PAID, T1,T2) Quality of Life (AQoL-8D, T1,T2) Patient Health Questionnaire (PHQ-9, T1,T2) Generalized Anxiety Disorder (GAD-7, T1,T2) Progredienzangst (PA-F-KF, T1,T2) Acceptance and Action Diabetes Questionnaire (AADQ, T1,T2) Diabetes Self-Care Questionnaire (DSMQ, T1,T2)	—

Measure

Time frame

Each measurements are questionnaires (self-report): T1: prior to intervention, T2: 8 weeks after randomization Problem Areas in Diabetes (PAID, T1,T2) Quality of Life (AQoL-8D, T1,T2) Patient Health Questionnaire (PHQ-9, T1,T2) Generalized Anxiety Disorder (GAD-7, T1,T2) Progredienzangst (PA-F-KF, T1,T2) Acceptance and Action Diabetes Questionnaire (AADQ, T1,T2) Diabetes Self-Care Questionnaire (DSMQ, T1,T2)

—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactEileen Bendig

Abteilung für klinische Psychologie und Psychotherapie, Institut für Psychologie und Pädagogik,Universität Ulm

eileen.bendig@uni-ulm.de0731 5032807

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 15, 2026